Smithson delivers ‘very small degree of outperformance’
As it divests two holdings for straying into non-core business areas
Smithson
-
-
Smithson appoints new chair
Mark Pacitti to retire at the end of February
-
Simon Barnard: Smithson should have theoretically underperformed in 2021
‘Very small degree of outperformance’ satisfies Fundsmith manager as Treasury yields rise
-
Fundsmith Smid trust gets first taste of underperformance
Smithson manager Simon Barnard says higher inflation unlikely to pose significant problems for portfolio companies
-
Smithson more than doubles benchmark return on healthcare boost
Top contributor to performance during the year was Danish healthcare equipment supplier Ambu
-
Outperforming Smithson trust buys ‘heavily’ during Covid crisis
Simon Barnard adds two names during H1 2020 and says crisis can be recovered from and forgotten
-
Smithson reveals stocks that have aided its coronavirus outperformance
Fundsmith investment trust delivers less than half the 23% falls seen in the MSCI index
-
Smithson makes first disposal after controversial CEO change
Fundsmith trust had wanted to reach its own conclusion on Brian Krzanich
-
Smithson reassures on liquidity as it raises extra £250m
Simon Barnard warns investors not to extrapolate too much from stellar H1 returns
-
Portfolio Adviser’s most-read investment trust stories of 2018
Baillie Gifford trusts caught readers’ attention this year alongside high-profile launches from Mobius and Fundsmith
-
Trust of trusts champions Mobius in recent spate of IPOs
Smithson and Merian fail to make the grade in the BMO Managed Portfolio
-
Smithson invests more than 95% of initial capital
‘Red October’ sell-off is likely to have made target stocks attractive
